• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病和阿尔茨海默病中与痴呆严重程度相匹配的脑代谢差异。

Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

作者信息

Vander Borght T, Minoshima S, Giordani B, Foster N L, Frey K A, Berent S, Albin R L, Koeppe R A, Kuhl D E

机构信息

Division of Nuclear Medicine, University of Michigan Medical School, USA.

出版信息

J Nucl Med. 1997 May;38(5):797-802.

PMID:9170449
Abstract

UNLABELLED

Despite controversial clinicopathological distinctions between Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD), similar patterns of metabolic reduction in the posterior brain were reported previously using PET with [18F]fluorodeoxyglucose. The current study was designed to examine more specific regional differences in cerebral glucose metabolism between PDD and AD using accurate and objective brain mapping techniques.

METHODS

This study included nine normal subjects, nine PDD patients and nine AD patients. PDD and AD groups were matched carefully for age, sex and general dementia severity as measured by Mini-Mental State Examination and Clinical Dementia Rating scales. Each subject underwent [18F]fluorodeoxyglucose-PET and neuropsychological testing. After anatomic standardization of PET image sets and stereotactic data extraction, absolute and normalized cerebral metabolic rates were assessed by region of interest and pixel-by-pixel analyses.

RESULTS

PDD and AD showed global glucose metabolic reduction with similar regional accentuation involving the lateral parietal, lateral temporal and lateral frontal association cortices and posterior cingulate cortex in comparison to normal controls. When comparing between PDD and AD, however, PDD showed greater metabolic reduction in the visual cortex and relatively preserved metabolism in the medial temporal cortex.

CONCLUSION

Although a common feature of metabolic abnormalities in the posterior brain exists in PDD and AD, the presence of regional metabolic differences suggests different degrees and combinations of disease specific underlying pathological and neurochemical processes.

摘要

未标记

尽管帕金森病痴呆(PDD)和阿尔茨海默病(AD)在临床病理特征上存在争议,但先前使用[18F]氟脱氧葡萄糖PET报告了后脑代谢降低的相似模式。本研究旨在使用准确且客观的脑图谱技术,检查PDD和AD之间脑葡萄糖代谢更具体的区域差异。

方法

本研究纳入9名正常受试者、9名PDD患者和9名AD患者。根据简易精神状态检查表和临床痴呆评定量表测量的年龄、性别和总体痴呆严重程度,对PDD组和AD组进行仔细匹配。每位受试者均接受[18F]氟脱氧葡萄糖PET检查和神经心理学测试。在对PET图像集进行解剖标准化和立体定向数据提取后,通过感兴趣区域和逐像素分析评估绝对和标准化脑代谢率。

结果

与正常对照组相比,PDD和AD均表现出整体葡萄糖代谢降低,且在外侧顶叶、外侧颞叶和外侧额叶联合皮质以及后扣带回皮质存在相似的区域强化。然而,在比较PDD和AD时,PDD在视觉皮质表现出更大程度的代谢降低,而内侧颞叶皮质的代谢相对保留。

结论

尽管PDD和AD在后脑存在代谢异常的共同特征,但区域代谢差异表明疾病特异性潜在病理和神经化学过程的程度和组合不同。

相似文献

1
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.帕金森病和阿尔茨海默病中与痴呆严重程度相匹配的脑代谢差异。
J Nucl Med. 1997 May;38(5):797-802.
2
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.痴呆症患者脑代谢衰退的纵向PET评估:阿尔茨海默病治疗研究中的一种潜在结局指标
Am J Psychiatry. 2002 May;159(5):738-45. doi: 10.1176/appi.ajp.159.5.738.
3
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.18F-FDG PET在阿尔茨海默病中的统计脑图谱:萎缩脑解剖标准化的验证
J Nucl Med. 2001 Apr;42(4):548-57.
4
Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.路易体痴呆、伴或不伴痴呆的帕金森病以及阿尔茨海默病的脑三维单光子发射计算机断层扫描(3D-SSP SPECT)分析
Clin Neurol Neurosurg. 2005 Aug;107(5):396-403. doi: 10.1016/j.clineuro.2004.12.005. Epub 2005 Jan 19.
5
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.极早期阿尔茨海默病患者后扣带回皮质的代谢降低
Ann Neurol. 1997 Jul;42(1):85-94. doi: 10.1002/ana.410420114.
6
Cerebral glucose metabolism in patients with frontotemporal dementia.额颞叶痴呆患者的脑葡萄糖代谢
J Nucl Med. 1998 Nov;39(11):1875-8.
7
[Cerebral glucose metabolism in Parkinson's disease with dementia].[帕金森病伴痴呆的脑葡萄糖代谢]
Zhonghua Yi Xue Za Zhi. 2008 Oct 14;88(37):2623-8.
8
Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.利用脑灌注单光子发射计算机断层扫描术早期诊断与痴呆相关的阿尔茨海默病和帕金森病。
Dement Geriatr Cogn Disord. 2014;37(5-6):276-85. doi: 10.1159/000357128. Epub 2013 Dec 14.
9
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.一种使用氟-18-氟代脱氧葡萄糖正电子发射断层显像(18F-FDG PET)三维立体定向表面投影技术诊断阿尔茨海默病的方法。
J Nucl Med. 1995 Jul;36(7):1238-48.
10
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.从帕金森病的动态氟代脱氧葡萄糖正电子发射断层扫描研究中确定区域速率常数。
J Nucl Med. 1996 Jul;37(7):1115-22.

引用本文的文献

1
Metabolomics in Parkinson's Disease and Correlation with Disease State.帕金森病中的代谢组学及其与疾病状态的相关性
Metabolites. 2025 Mar 18;15(3):208. doi: 10.3390/metabo15030208.
2
The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.[具体内容]对帕金森病和帕金森综合征认知障碍的作用。 需注意,原文中“on cognitive impairment”前似乎缺失了关键信息。
Front Neurosci. 2025 Feb 20;19:1515374. doi: 10.3389/fnins.2025.1515374. eCollection 2025.
3
Neuroimaging Biomarkers in Parkinson's Disease.帕金森病的神经影像学标志物。
Adv Neurobiol. 2024;40:617-663. doi: 10.1007/978-3-031-69491-2_21.
4
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
5
Regional Metabolic Changes Influencing Three-Dimensional Perception in Parkinson's Disease.影响帕金森病三维感知的区域代谢变化
J Clin Neurol. 2022 Jul;18(4):447-452. doi: 10.3988/jcn.2022.18.4.447.
6
Striatal Dopaminergic Depletion Pattern Reflects Pathological Brain Perfusion Changes in Lewy Body Diseases.纹状体多巴胺能缺失模式反映路易体病的病理性脑灌注变化。
Mol Imaging Biol. 2022 Dec;24(6):950-958. doi: 10.1007/s11307-022-01745-x. Epub 2022 Jun 14.
7
Glycolytic metabolism supports microglia training during age-related neurodegeneration.糖酵解代谢支持衰老相关神经退行性变过程中小胶质细胞的训练。
Pharmacol Rep. 2022 Oct;74(5):818-831. doi: 10.1007/s43440-022-00363-2. Epub 2022 Apr 3.
8
Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease.帕金森病中轻度认知障碍和痴呆的影像学表现
Front Neurol. 2020 Jan 31;11:47. doi: 10.3389/fneur.2020.00047. eCollection 2020.
9
Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease.帕金森病中痴呆、疲劳和抑郁的生物标志物。
Front Neurol. 2019 Mar 8;10:195. doi: 10.3389/fneur.2019.00195. eCollection 2019.
10
Dementia spectrum disorders: lessons learnt from decades with PET research.痴呆谱系障碍:从数十年的 PET 研究中吸取的经验教训。
J Neural Transm (Vienna). 2019 Mar;126(3):233-251. doi: 10.1007/s00702-019-01975-4. Epub 2019 Feb 14.